MarketInOut Stock Screener Log In | Sign Up

Embracing Future Holdings Ltd

SES • Healthcare • Diagnostics & Research • Quote as of 10/27/2026
Embracing Future Holdings Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeSES
Market Capitalization41.6 mln
Float470 mln
Earnings Date11/04/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

0.28
Highly suspicious

Relative Strength

3 / 100
Severely lagging

Debt / Equity

0.21
Very low leverage

Pre-Tax Margin

-45%
Deeply loss-making

ROE

-205
Deeply negative

Business Description

Embracing Future Holdings Limited is a Singapore-based medical technology company founded in 2009 that specializes in precision diagnostics, with operations spanning Singapore, China, and Hong Kong. Its flagship products include an automated system for isolating living tumour cells from blood samples, supporting earlier and more accurate cancer detection. Beyond healthcare, the company is also active in biomedical product distribution, gaming industry marketing, and live-streaming services. Previously called Biolidics Limited, the company adopted its current name in June 2025.

Key Fundamentals

EPS-0.00
ROE-205
RPS0.00
ROIC-63.07
ROA-59.15
Interest Cover-31.68
EBITDA, mln-2.63
EV / EBITDA-23.02
EV / EBIT-20.09
Revenue, mln6.82
EV / Revenue8.88

Quote Details

Last 0.026
Change 0 (0%)
Open 0.026
Volume 3,502,200
Turnover 91,057
Average Volume 843,026

Financial Ratios

Pre-Tax Profit Margin-45
Leverage Ratio3.05
Current Ratio1.39
Price / Book34.00
Price / Cash Flow106
Price / Free Cash Flow106
Debt / Equity0.21
Price / Sales8.50

Financial Strength

Altman Z-Score-12.18
Piotroski F-Score 5 / 9
Beneish M-Score0.28

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -16.13% 2 / 100   
1 Month -27.78% 4 / 100   
2 Months -36.59% 7 / 100   
6 Months -48% 5 / 100   
1 Year 13.04% 72 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog